Chemoprevention of pancreatic ductal carcinoma by targeting for GST-π

• Project/Area Number: 21790677
• Research Category: Grant-in-Aid for Young Scientists (B)
• Allocation Type: Single-year Grants
• Research Field: Gastroenterology
• Research Institution: Sapporo Medical University
• Principal Investigator: HAYASHI Tsuyoshi Sapporo Medical University, 医学部, 助教 (60381258)
• Project Period (FY): 2009 – 2010
• Project Status: Completed (Fiscal Year 2010)
• Budget Amount: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000); Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000); Fiscal Year 2009: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
• Keywords: 医療・福祉 / 癌

Research Abstract

As we have finished the preparation of drug for double blinded study, we are now conducting a randomized controlled trial for evaluating of suppressive effect of sulindac on branch duct type intraductal papillary mucinous neoplasms (BD-IPMN). We believe that our future results will contribute to the establishment of the chemoprevention of pancreatic ductal carcinoma derived from BD-IPMN.

Research Products

• [Journal Article] Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms. (2009)
  • Author(s): Hayashi T, Ishiwatari H, Ihara H, Kawano Y, Takada K, Miyanishi K, Kobune M, Takimoto R, Sonoda T, Takayama T, Kato J, Niitsu Y
  • Journal Title: Journal of Gastroenterology Volume 44, Number 9(発行) Pages: 964-975
  • NAID: 10025581446
  • Peer Reviewed